Erbitux 100 mg Injection 20 ml Substitute
Merck Ltd
₹20500
(₹1025.0/ 1ml)
Merck Ltd
₹102500
(₹1025.0/ 1ml)

Patients may explore substitutes in the following scenarios:
Before you switch from Erbitux 100 mg Injection 20 ml to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - CETUXIMAB-5MG, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Erbitux 100 mg Injection 20 ml is used to treat certain types of cancers. The detailed uses of Erbitux 100 mg Injection 20 ml are as follows:
Erbitux 100 mg Injection 20 ml is a monoclonal antibody. It is used alone or in combination with other anticancer medications to treat various cancer diseases, including metastatic cancer of the large intestine and squamous cell cancer (a form of head and neck cancer). Cetuximab is present in Erbitux 100 mg Injection 20 ml and works by slowing or preventing the growth of cancer cells. As a result, it inhibits the cancer from spreading.
The substitutes of Erbitux 100 mg Injection 20 ml contain the same active salt(s) - CETUXIMAB-5MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Erbitux 100 mg Injection 20 ml is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Erbitux 100 mg Injection 20 ml are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Erbitux 100 mg Injection 20 ml meet the same safety and efficacy standards as Erbitux 100 mg Injection 20 ml, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Erbitux 100 mg Injection 20 ml may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Erbitux 100 mg Injection 20 ml if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Erbitux 100 mg Injection 20 ml for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Erbitux 100 mg Injection 20 ml is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Erbitux 100 mg Injection 20 ml to its substitute. Always consult your doctor before switching.
Erbitux 100 mg Injection 20 ml is used to treat Cancer.
Erbitux 100 mg Injection 20 ml contains Cetuximab, which works by slowing or stopping the growth of cancer cells. Thereby, it prevents the cancer from spreading.
Attend all your doctor's appointments while taking Erbitux 100 mg Injection 20 ml to ensure the therapy is effective. Regular blood tests and weight checks must be performed. While taking the Erbitux 100 mg Injection 20 ml, both men and women should use an effective means of contraception. Do not use any other medications unless prescribed by the doctor. If you have low levels of Magnesium and Calcium in your blood, inform your doctor before treating you with this medicine.
Do not stop taking Erbitux 100 mg Injection 20 ml on your own. Take Erbitux 100 mg Injection 20 ml for as long as your doctor prescribes it, depending on your medical condition. Do not miss any scheduled dose. Speak with your doctor if you experience difficulty using Erbitux 100 mg Injection 20 ml.
Some dietary changes can help you manage side effects; for example, in case of diarrhoea-Choose foods or drinks with sodium (sports drinks or broth) and potassium (bananas and all-natural fruit juices).
Yes, Erbitux 100 mg Injection 20 ml is a chemotherapy drug, but it is specifically classified as a monoclonal antibody. It works by targeting and blocking the epidermal growth factor receptor (EGFR) on cancer cells, which helps slow or stop tumour growth. It is used primarily for the treatment of certain types of cancers, such as colorectal cancer and head and neck cancers.
Erbitux 100 mg Injection 20 ml is a monoclonal antibody used to treat cancer. It is neither a cytotoxic agent nor a vesicant, but it acts as a radio sensitizer by enhancing the effects of radiation therapy on cancer cells.
Erbitux 100 mg Injection 20 ml is administered through intravenous infusion by the doctor or nurse. The infusion is typically given over a period of time, with the rate depending on the patient's tolerance and the treatment plan. Do not self-administer.
Yes, Erbitux 100 mg Injection 20 ml may cause hair loss as a common side effect. If you experience this symptom, manage stress, use gentle hair care practices, and eat nutritious food. However, if hair loss persists consult the doctor for further guidance.
Erbitux 100 mg Injection 20 ml may cause a rash as a side effect because it targets and blocks the epidermal growth factor receptor (EGFR), which plays a key role in skin cell growth and repair. Inhibiting EGFR can lead to skin inflammation and reactions, resulting in the rash. However, consult the doctor if this symptom persists or worsens.
The duration of a rash depends on its cause. Some rashes may last for only a few days, while others can persist for weeks or even months. If the rash persists or worsens, consult the doctor for proper diagnosis and treatment.
The side effects of Erbitux 100 mg Injection 20 ml include headache, inflammation of the lining of the intestine, mouth, and nose, nose bleeding, tiredness, irritation and redness of the eye, diarrhoea, feeling sick, vomiting, loss of appetite, and weight loss. Consult the doctor if any of these symptoms persist or worsen.
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Celon Laboratories Pvt Ltd
Natco Pharma Ltd
Admac Lifesciences(Oncology)
Cipla Ltd
BDR Pharmaceuticals Internationals Pvt Ltd
Sun Pharmaceutical Industries Ltd
Halsted Pharma Pvt Ltd
Adley Formulations
Neon Laboratories Ltd
Samarth Life Sciences Pvt Ltd
United Biotech Pvt Ltd
Glenmark Pharmaceuticals Ltd
Alkem Laboratories Ltd
Zydus Cadila
Emcure Pharmaceuticals Ltd
Zydus Healthcare Ltd
GLS Pharma Ltd
Axiommax Oncology Pvt Ltd
Hetero Healthcare Pvt Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
Torrent Pharmaceuticals Ltd
Fresenius Kabi India Pvt Ltd
Therdose Pharma Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Pfizer Ltd
Zee Laboratories Ltd
Medion Biotech Pvt Ltd
Msn Laboratories Pvt Ltd
Lupin Ltd
Cadila Healthcare Ltd
Getwell Life Sciences India Pvt Ltd
RPG Life Sciences Ltd
Novartis India Ltd
Shilpa Medicare Ltd
Aureate Healthcare
Biochem Pharmaceutical Industries Ltd
Zuvius Lifesciences Pvt Ltd
Abbott India Ltd
Wembrace Biopharma Pvt Ltd
Adley Pharmaceuticals Ltd
Cadila Pharmaceuticals Ltd
Delarc Pharmaceuticals Pvt Ltd
Biomak Laboratories Pvt Ltd
Lucien Life Sciences
Reliance Formulation Pvt Ltd
Amps Biotech Biotech Pvt Ltd
Aimcad Biotech Pvt Ltd
Astra Zeneca Pharma India Ltd
Getwell Oncology Pvt Ltd
MEDICAMEN BIOTECH LTD
Reliance Life Sciences Pvt Ltd
Del Trade International Pvt Ltd
Getwell Pharmaceutical Pvt Ltd
Panacea Biotec Ltd
Bhardwaj India Pvt Ltd
Caitlin Oncology
Dabur India Ltd
Medaegis Biotek Pvt Ltd
Medicamen Biotech Ltd
PHARMACO INDUSTRIES PVT LTD
Oncostar Pharma Pvt Ltd
Sarabhai Chemicals (India) Pvt Ltd
Adley Oncology
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
ANAKAAS LIFE BIO SCIENCE PVT LTD.
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cytogen
Eli Lilly and Company (India) Pvt Ltd
Symbion Lifescience
Vhb Life Sciences Inc
Bruck Pharma Pvt Ltd
Eris Life Sciences Ltd
Hilfen Pharmaceuticals Pvt Ltd
Miracalus Pharma Pvt Ltd
Roche Diagnostics India Pvt Ltd
Zuventus Healthcare Ltd
Admac Pharma Ltd
Anakaas Life Bio Science Pvt Ltd
Aprazer Healthcare Pvt Ltd
Johnson & Johnson Pvt Ltd
KLIN LABORATORIES PVT. LTD.
Maximal Healthcare Pvt Ltd
Oncobiotek Drugs Pvt Ltd
Sayre Therapeutics Pvt Ltd
Adley & Bdl
Akumentis Healthcare Ltd
Biocon Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Hetero Healthcare Ltd
MEDICAMEN BIOTECH LIMITED
Mankind Pharma Pvt Ltd
Merck Ltd
Prevego Healthcare & Research Pvt Ltd
RX